Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.
about
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).Survival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplantGlobal characteristics of childhood acute promyelocytic leukemia.Cancer Survivorship Care: Summarizing the 6 Tools for Success.Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapyClinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia.Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation.Hematopoietic stem cell transplantation for hematological malignancies in Europe.
P2860
Q35153809-C564947D-9B83-4054-9FC1-AEA240AA673AQ35189037-EBFB0ED5-923D-4E0C-8060-DF32E176BCAFQ35231673-223EEF60-BADD-4A8A-B620-FB0233BFC1FBQ35598437-4E6A4F83-0570-4239-8752-F18F80CA59EAQ36246359-6A689A63-817C-4447-B924-59F545CC5631Q37121665-77F00D07-7606-44D9-838A-AF4E54851676Q37323006-BE1DC302-BA46-4C06-9F47-D02FB2C61623Q40542436-D8CFF17A-868F-40DA-96C7-4A15EBB6451EQ40897000-421B985F-3138-4633-9C36-E74EE35B675DQ46535096-D52F2814-4327-4870-BCC6-203138B334BFQ46656673-1ACAF01C-C91C-4604-8A82-E4451BC30C52Q46940777-BF47910C-A93F-4686-B73A-D1DA78E9ADE8Q47908471-A0BFBFED-70B1-4B43-AE7E-0F8B9EFA26FD
P2860
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Factors influencing outcome an ...... a in first complete remission.
@en
Factors influencing outcome an ...... a in first complete remission.
@nl
type
label
Factors influencing outcome an ...... a in first complete remission.
@en
Factors influencing outcome an ...... a in first complete remission.
@nl
prefLabel
Factors influencing outcome an ...... a in first complete remission.
@en
Factors influencing outcome an ...... a in first complete remission.
@nl
P2093
P50
P1433
P1476
Factors influencing outcome an ...... a in first complete remission.
@en
P2093
Augustin Ferrant
Chiara Messina
European Blood and Marrow Transplantation Acute Leukemia Working Party
Gerard Sociè
Giorgio Dini
Giovanna Meloni
Isaac Yaniv
Juan Ortega
Myriam Labopin
P304
P356
10.1182/BLOOD-2002-03-0764
P407
P577
2002-10-10T00:00:00Z